Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice
Identifieur interne : 003000 ( Main/Exploration ); précédent : 002F99; suivant : 003001Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice
Auteurs : Michelle M. Becker ; Rachel L. Graham ; Eric F. Donaldson ; Barry Rockx ; Amy C. Sims [États-Unis] ; Timothy Sheahan ; Raymond J. Pickles ; Davide Corti [Suisse] ; Robert E. Johnston [États-Unis] ; Ralph S. Baric [États-Unis] ; Mark R. Denison [États-Unis]Source :
- Proceedings of the National Academy of Sciences of the United States of America [ 0027-8424 ] ; 2008.
Descripteurs français
- KwdFr :
- Animaux, Cellules Vero, Cellules cultivées, Chiroptera (virologie), Données de séquences moléculaires, Femelle, Glycoprotéine de spicule des coronavirus, Glycoprotéines membranaires (génétique), Humains, Muqueuse respiratoire (virologie), Protéines de l'enveloppe virale (génétique), Protéines recombinantes (génétique), Recombinaison génétique, Réplication virale, Souris, Souris de lignée BALB C, Syndrome respiratoire aigu sévère (virologie), Séquence d'acides aminés, Virus du SRAS (génétique), Virus du SRAS (isolement et purification), Virus du SRAS (physiologie), Zoonoses (transmission), Zoonoses (virologie).
- MESH :
- génétique : Glycoprotéines membranaires, Protéines de l'enveloppe virale, Protéines recombinantes, Virus du SRAS.
- isolement et purification : Virus du SRAS.
- physiologie : Virus du SRAS.
- virologie : Chiroptera, Muqueuse respiratoire, Syndrome respiratoire aigu sévère, Zoonoses.
- transmission : Animaux, Cellules Vero, Cellules cultivées, Données de séquences moléculaires, Femelle, Glycoprotéine de spicule des coronavirus, Humains, Recombinaison génétique, Réplication virale, Souris, Souris de lignée BALB C, Séquence d'acides aminés, Zoonoses.
English descriptors
- KwdEn :
- Amino Acid Sequence, Animals, Cells, Cultured, Chiroptera (virology), Chlorocebus aethiops, Female, Humans, Membrane Glycoproteins (genetics), Mice, Mice, Inbred BALB C, Molecular Sequence Data, Recombinant Proteins (genetics), Recombination, Genetic, Respiratory Mucosa (virology), SARS Virus (genetics), SARS Virus (isolation & purification), SARS Virus (physiology), Severe Acute Respiratory Syndrome (virology), Spike Glycoprotein, Coronavirus, Vero Cells, Viral Envelope Proteins (genetics), Virus Replication, Zoonoses (transmission), Zoonoses (virology).
- MESH :
- chemical , genetics : Membrane Glycoproteins, Recombinant Proteins, Viral Envelope Proteins.
- genetics : SARS Virus.
- isolation & purification : SARS Virus.
- physiology : SARS Virus.
- transmission : Zoonoses.
- virology : Chiroptera, Respiratory Mucosa, Severe Acute Respiratory Syndrome, Zoonoses.
- Amino Acid Sequence, Animals, Cells, Cultured, Chlorocebus aethiops, Female, Humans, Mice, Mice, Inbred BALB C, Molecular Sequence Data, Recombination, Genetic, Spike Glycoprotein, Coronavirus, Vero Cells, Virus Replication.
Abstract
Defining prospective pathways by which zoonoses evolve and emerge as human pathogens is critical for anticipating and controlling both natural and deliberate pandemics. However, predicting tenable pathways of animal-to-human movement has been hindered by challenges in identifying reservoir species, cultivating zoonotic organisms in culture, and isolating full-length genomes for cloning and genetic studies. The ability to design and recover pathogens reconstituted from synthesized cDNAs has the potential to overcome these obstacles by allowing studies of replication and pathogenesis without identification of reservoir species or cultivation of primary isolates. Here, we report the design, synthesis, and recovery of the largest synthetic replicating life form, a 29.7-kb bat severe acute respiratory syndrome (SARS)-like coronavirus (Bat-SCoV), a likely progenitor to the SARS-CoV epidemic. To test a possible route of emergence from the noncultivable Bat-SCoV to human SARS-CoV, we designed a consensus Bat-SCoV genome and replaced the Bat-SCoV Spike receptor-binding domain (RBD) with the SARS-CoV RBD (Bat-SRBD). Bat-SRBD was infectious in cell culture and in mice and was efficiently neutralized by antibodies specific for both bat and human CoV Spike proteins. Rational design, synthesis, and recovery of hypothetical recombinant viruses can be used to investigate mechanisms of transspecies movement of zoonoses and has great potential to aid in rapid public health responses to known or predicted emerging microbial threats.
Url:
DOI: 10.1073/pnas.0808116105
PubMed: 19036930
PubMed Central: 2588415
Affiliations:
Links toward previous steps (curation, corpus...)
- to stream Pmc, to step Corpus: 000D14
- to stream Pmc, to step Curation: 000D14
- to stream Pmc, to step Checkpoint: 000D72
- to stream PubMed, to step Corpus: 001A26
- to stream PubMed, to step Curation: 001A26
- to stream PubMed, to step Checkpoint: 001A00
- to stream Ncbi, to step Merge: 001D94
- to stream Ncbi, to step Curation: 001D94
- to stream Ncbi, to step Checkpoint: 001D94
- to stream Main, to step Merge: 003068
- to stream Main, to step Curation: 003000
Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice</title><author><name sortKey="Becker, Michelle M" sort="Becker, Michelle M" uniqKey="Becker M" first="Michelle M." last="Becker">Michelle M. Becker</name><affiliation><nlm:aff id="aff1"></nlm:aff></affiliation></author><author><name sortKey="Graham, Rachel L" sort="Graham, Rachel L" uniqKey="Graham R" first="Rachel L." last="Graham">Rachel L. Graham</name><affiliation><nlm:aff id="aff3"></nlm:aff></affiliation></author><author><name sortKey="Donaldson, Eric F" sort="Donaldson, Eric F" uniqKey="Donaldson E" first="Eric F." last="Donaldson">Eric F. Donaldson</name><affiliation><nlm:aff id="aff3"></nlm:aff></affiliation></author><author><name sortKey="Rockx, Barry" sort="Rockx, Barry" uniqKey="Rockx B" first="Barry" last="Rockx">Barry Rockx</name><affiliation><nlm:aff id="aff3"></nlm:aff></affiliation></author><author><name sortKey="Sims, Amy C" sort="Sims, Amy C" uniqKey="Sims A" first="Amy C." last="Sims">Amy C. Sims</name><affiliation><nlm:aff id="aff3"></nlm:aff></affiliation><affiliation wicri:level="2"><nlm:aff wicri:cut="; and" id="aff6">Carolina Vaccine Institute, University of North Carolina, Chapel Hill, NC 27599</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Nord</region></placeName><wicri:cityArea>Carolina Vaccine Institute, University of North Carolina, Chapel Hill</wicri:cityArea></affiliation></author><author><name sortKey="Sheahan, Timothy" sort="Sheahan, Timothy" uniqKey="Sheahan T" first="Timothy" last="Sheahan">Timothy Sheahan</name><affiliation><nlm:aff id="aff3"></nlm:aff></affiliation></author><author><name sortKey="Pickles, Raymond J" sort="Pickles, Raymond J" uniqKey="Pickles R" first="Raymond J." last="Pickles">Raymond J. Pickles</name><affiliation><nlm:aff id="aff4">Microbiology and Immunology,</nlm:aff></affiliation><affiliation><nlm:aff wicri:cut=", and" id="aff5">Cystic Fibrosis/Pulmonary Research and Treatment Center and Department of Medicine</nlm:aff></affiliation></author><author><name sortKey="Corti, Davide" sort="Corti, Davide" uniqKey="Corti D" first="Davide" last="Corti">Davide Corti</name><affiliation wicri:level="1"><nlm:aff id="aff7">Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland</nlm:aff><country xml:lang="fr">Suisse</country><wicri:regionArea>Institute for Research in Biomedicine, CH-6500 Bellinzona</wicri:regionArea><wicri:noRegion>CH-6500 Bellinzona</wicri:noRegion></affiliation></author><author><name sortKey="Johnston, Robert E" sort="Johnston, Robert E" uniqKey="Johnston R" first="Robert E." last="Johnston">Robert E. Johnston</name><affiliation wicri:level="2"><nlm:aff wicri:cut="; and" id="aff6">Carolina Vaccine Institute, University of North Carolina, Chapel Hill, NC 27599</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Nord</region></placeName><wicri:cityArea>Carolina Vaccine Institute, University of North Carolina, Chapel Hill</wicri:cityArea></affiliation></author><author><name sortKey="Baric, Ralph S" sort="Baric, Ralph S" uniqKey="Baric R" first="Ralph S." last="Baric">Ralph S. Baric</name><affiliation><nlm:aff id="aff3"></nlm:aff></affiliation><affiliation wicri:level="2"><nlm:aff wicri:cut="; and" id="aff6">Carolina Vaccine Institute, University of North Carolina, Chapel Hill, NC 27599</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Nord</region></placeName><wicri:cityArea>Carolina Vaccine Institute, University of North Carolina, Chapel Hill</wicri:cityArea></affiliation><affiliation><nlm:aff id="aff4">Microbiology and Immunology,</nlm:aff></affiliation></author><author><name sortKey="Denison, Mark R" sort="Denison, Mark R" uniqKey="Denison M" first="Mark R." last="Denison">Mark R. Denison</name><affiliation><nlm:aff id="aff1"></nlm:aff></affiliation><affiliation wicri:level="2"><nlm:aff id="aff2">Microbiology and Immunology, Vanderbilt University, Nashville, TN 37232;</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Tennessee</region></placeName><wicri:cityArea>Microbiology and Immunology, Vanderbilt University, Nashville</wicri:cityArea></affiliation></author></titleStmt><publicationStmt><idno type="wicri:source">PMC</idno><idno type="pmid">19036930</idno><idno type="pmc">2588415</idno><idno type="url">http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2588415</idno><idno type="RBID">PMC:2588415</idno><idno type="doi">10.1073/pnas.0808116105</idno><date when="2008">2008</date><idno type="wicri:Area/Pmc/Corpus">000D14</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Corpus" wicri:corpus="PMC">000D14</idno><idno type="wicri:Area/Pmc/Curation">000D14</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Curation">000D14</idno><idno type="wicri:Area/Pmc/Checkpoint">000D72</idno><idno type="wicri:explorRef" wicri:stream="Pmc" wicri:step="Checkpoint">000D72</idno><idno type="wicri:source">PubMed</idno><idno type="RBID">pubmed:19036930</idno><idno type="wicri:Area/PubMed/Corpus">001A26</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">001A26</idno><idno type="wicri:Area/PubMed/Curation">001A26</idno><idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">001A26</idno><idno type="wicri:Area/PubMed/Checkpoint">001A00</idno><idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">001A00</idno><idno type="wicri:Area/Ncbi/Merge">001D94</idno><idno type="wicri:Area/Ncbi/Curation">001D94</idno><idno type="wicri:Area/Ncbi/Checkpoint">001D94</idno><idno type="wicri:doubleKey">0027-8424:2008:Becker M:synthetic:recombinant:bat</idno><idno type="wicri:Area/Main/Merge">003068</idno><idno type="wicri:Area/Main/Curation">003000</idno><idno type="wicri:Area/Main/Exploration">003000</idno></publicationStmt><sourceDesc><biblStruct><analytic><title xml:lang="en" level="a" type="main">Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice</title><author><name sortKey="Becker, Michelle M" sort="Becker, Michelle M" uniqKey="Becker M" first="Michelle M." last="Becker">Michelle M. Becker</name><affiliation><nlm:aff id="aff1"></nlm:aff></affiliation></author><author><name sortKey="Graham, Rachel L" sort="Graham, Rachel L" uniqKey="Graham R" first="Rachel L." last="Graham">Rachel L. Graham</name><affiliation><nlm:aff id="aff3"></nlm:aff></affiliation></author><author><name sortKey="Donaldson, Eric F" sort="Donaldson, Eric F" uniqKey="Donaldson E" first="Eric F." last="Donaldson">Eric F. Donaldson</name><affiliation><nlm:aff id="aff3"></nlm:aff></affiliation></author><author><name sortKey="Rockx, Barry" sort="Rockx, Barry" uniqKey="Rockx B" first="Barry" last="Rockx">Barry Rockx</name><affiliation><nlm:aff id="aff3"></nlm:aff></affiliation></author><author><name sortKey="Sims, Amy C" sort="Sims, Amy C" uniqKey="Sims A" first="Amy C." last="Sims">Amy C. Sims</name><affiliation><nlm:aff id="aff3"></nlm:aff></affiliation><affiliation wicri:level="2"><nlm:aff wicri:cut="; and" id="aff6">Carolina Vaccine Institute, University of North Carolina, Chapel Hill, NC 27599</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Nord</region></placeName><wicri:cityArea>Carolina Vaccine Institute, University of North Carolina, Chapel Hill</wicri:cityArea></affiliation></author><author><name sortKey="Sheahan, Timothy" sort="Sheahan, Timothy" uniqKey="Sheahan T" first="Timothy" last="Sheahan">Timothy Sheahan</name><affiliation><nlm:aff id="aff3"></nlm:aff></affiliation></author><author><name sortKey="Pickles, Raymond J" sort="Pickles, Raymond J" uniqKey="Pickles R" first="Raymond J." last="Pickles">Raymond J. Pickles</name><affiliation><nlm:aff id="aff4">Microbiology and Immunology,</nlm:aff></affiliation><affiliation><nlm:aff wicri:cut=", and" id="aff5">Cystic Fibrosis/Pulmonary Research and Treatment Center and Department of Medicine</nlm:aff></affiliation></author><author><name sortKey="Corti, Davide" sort="Corti, Davide" uniqKey="Corti D" first="Davide" last="Corti">Davide Corti</name><affiliation wicri:level="1"><nlm:aff id="aff7">Institute for Research in Biomedicine, CH-6500 Bellinzona, Switzerland</nlm:aff><country xml:lang="fr">Suisse</country><wicri:regionArea>Institute for Research in Biomedicine, CH-6500 Bellinzona</wicri:regionArea><wicri:noRegion>CH-6500 Bellinzona</wicri:noRegion></affiliation></author><author><name sortKey="Johnston, Robert E" sort="Johnston, Robert E" uniqKey="Johnston R" first="Robert E." last="Johnston">Robert E. Johnston</name><affiliation wicri:level="2"><nlm:aff wicri:cut="; and" id="aff6">Carolina Vaccine Institute, University of North Carolina, Chapel Hill, NC 27599</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Nord</region></placeName><wicri:cityArea>Carolina Vaccine Institute, University of North Carolina, Chapel Hill</wicri:cityArea></affiliation></author><author><name sortKey="Baric, Ralph S" sort="Baric, Ralph S" uniqKey="Baric R" first="Ralph S." last="Baric">Ralph S. Baric</name><affiliation><nlm:aff id="aff3"></nlm:aff></affiliation><affiliation wicri:level="2"><nlm:aff wicri:cut="; and" id="aff6">Carolina Vaccine Institute, University of North Carolina, Chapel Hill, NC 27599</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Caroline du Nord</region></placeName><wicri:cityArea>Carolina Vaccine Institute, University of North Carolina, Chapel Hill</wicri:cityArea></affiliation><affiliation><nlm:aff id="aff4">Microbiology and Immunology,</nlm:aff></affiliation></author><author><name sortKey="Denison, Mark R" sort="Denison, Mark R" uniqKey="Denison M" first="Mark R." last="Denison">Mark R. Denison</name><affiliation><nlm:aff id="aff1"></nlm:aff></affiliation><affiliation wicri:level="2"><nlm:aff id="aff2">Microbiology and Immunology, Vanderbilt University, Nashville, TN 37232;</nlm:aff><country xml:lang="fr">États-Unis</country><placeName><region type="state">Tennessee</region></placeName><wicri:cityArea>Microbiology and Immunology, Vanderbilt University, Nashville</wicri:cityArea></affiliation></author></analytic><series><title level="j">Proceedings of the National Academy of Sciences of the United States of America</title><idno type="ISSN">0027-8424</idno><idno type="eISSN">1091-6490</idno><imprint><date when="2008">2008</date></imprint></series></biblStruct></sourceDesc></fileDesc><profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Amino Acid Sequence</term><term>Animals</term><term>Cells, Cultured</term><term>Chiroptera (virology)</term><term>Chlorocebus aethiops</term><term>Female</term><term>Humans</term><term>Membrane Glycoproteins (genetics)</term><term>Mice</term><term>Mice, Inbred BALB C</term><term>Molecular Sequence Data</term><term>Recombinant Proteins (genetics)</term><term>Recombination, Genetic</term><term>Respiratory Mucosa (virology)</term><term>SARS Virus (genetics)</term><term>SARS Virus (isolation & purification)</term><term>SARS Virus (physiology)</term><term>Severe Acute Respiratory Syndrome (virology)</term><term>Spike Glycoprotein, Coronavirus</term><term>Vero Cells</term><term>Viral Envelope Proteins (genetics)</term><term>Virus Replication</term><term>Zoonoses (transmission)</term><term>Zoonoses (virology)</term></keywords><keywords scheme="KwdFr" xml:lang="fr"><term>Animaux</term><term>Cellules Vero</term><term>Cellules cultivées</term><term>Chiroptera (virologie)</term><term>Données de séquences moléculaires</term><term>Femelle</term><term>Glycoprotéine de spicule des coronavirus</term><term>Glycoprotéines membranaires (génétique)</term><term>Humains</term><term>Muqueuse respiratoire (virologie)</term><term>Protéines de l'enveloppe virale (génétique)</term><term>Protéines recombinantes (génétique)</term><term>Recombinaison génétique</term><term>Réplication virale</term><term>Souris</term><term>Souris de lignée BALB C</term><term>Syndrome respiratoire aigu sévère (virologie)</term><term>Séquence d'acides aminés</term><term>Virus du SRAS (génétique)</term><term>Virus du SRAS (isolement et purification)</term><term>Virus du SRAS (physiologie)</term><term>Zoonoses (transmission)</term><term>Zoonoses (virologie)</term></keywords><keywords scheme="MESH" type="chemical" qualifier="genetics" xml:lang="en"><term>Membrane Glycoproteins</term><term>Recombinant Proteins</term><term>Viral Envelope Proteins</term></keywords><keywords scheme="MESH" qualifier="genetics" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="génétique" xml:lang="fr"><term>Glycoprotéines membranaires</term><term>Protéines de l'enveloppe virale</term><term>Protéines recombinantes</term><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="isolation & purification" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="isolement et purification" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Virus du SRAS</term></keywords><keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>SARS Virus</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="en"><term>Zoonoses</term></keywords><keywords scheme="MESH" qualifier="virologie" xml:lang="fr"><term>Chiroptera</term><term>Muqueuse respiratoire</term><term>Syndrome respiratoire aigu sévère</term><term>Zoonoses</term></keywords><keywords scheme="MESH" qualifier="virology" xml:lang="en"><term>Chiroptera</term><term>Respiratory Mucosa</term><term>Severe Acute Respiratory Syndrome</term><term>Zoonoses</term></keywords><keywords scheme="MESH" xml:lang="en"><term>Amino Acid Sequence</term><term>Animals</term><term>Cells, Cultured</term><term>Chlorocebus aethiops</term><term>Female</term><term>Humans</term><term>Mice</term><term>Mice, Inbred BALB C</term><term>Molecular Sequence Data</term><term>Recombination, Genetic</term><term>Spike Glycoprotein, Coronavirus</term><term>Vero Cells</term><term>Virus Replication</term></keywords><keywords scheme="MESH" qualifier="transmission" xml:lang="fr"><term>Animaux</term><term>Cellules Vero</term><term>Cellules cultivées</term><term>Données de séquences moléculaires</term><term>Femelle</term><term>Glycoprotéine de spicule des coronavirus</term><term>Humains</term><term>Recombinaison génétique</term><term>Réplication virale</term><term>Souris</term><term>Souris de lignée BALB C</term><term>Séquence d'acides aminés</term><term>Zoonoses</term></keywords></textClass></profileDesc></teiHeader><front><div type="abstract" xml:lang="en"><p>Defining prospective pathways by which zoonoses evolve and emerge as human pathogens is critical for anticipating and controlling both natural and deliberate pandemics. However, predicting tenable pathways of animal-to-human movement has been hindered by challenges in identifying reservoir species, cultivating zoonotic organisms in culture, and isolating full-length genomes for cloning and genetic studies. The ability to design and recover pathogens reconstituted from synthesized cDNAs has the potential to overcome these obstacles by allowing studies of replication and pathogenesis without identification of reservoir species or cultivation of primary isolates. Here, we report the design, synthesis, and recovery of the largest synthetic replicating life form, a 29.7-kb bat severe acute respiratory syndrome (SARS)-like coronavirus (Bat-SCoV), a likely progenitor to the SARS-CoV epidemic. To test a possible route of emergence from the noncultivable Bat-SCoV to human SARS-CoV, we designed a consensus Bat-SCoV genome and replaced the Bat-SCoV Spike receptor-binding domain (RBD) with the SARS-CoV RBD (Bat-SRBD). Bat-SRBD was infectious in cell culture and in mice and was efficiently neutralized by antibodies specific for both bat and human CoV Spike proteins. Rational design, synthesis, and recovery of hypothetical recombinant viruses can be used to investigate mechanisms of transspecies movement of zoonoses and has great potential to aid in rapid public health responses to known or predicted emerging microbial threats.</p></div></front></TEI><affiliations><list><country><li>Suisse</li><li>États-Unis</li></country><region><li>Caroline du Nord</li><li>Tennessee</li></region></list><tree><noCountry><name sortKey="Becker, Michelle M" sort="Becker, Michelle M" uniqKey="Becker M" first="Michelle M." last="Becker">Michelle M. Becker</name><name sortKey="Donaldson, Eric F" sort="Donaldson, Eric F" uniqKey="Donaldson E" first="Eric F." last="Donaldson">Eric F. Donaldson</name><name sortKey="Graham, Rachel L" sort="Graham, Rachel L" uniqKey="Graham R" first="Rachel L." last="Graham">Rachel L. Graham</name><name sortKey="Pickles, Raymond J" sort="Pickles, Raymond J" uniqKey="Pickles R" first="Raymond J." last="Pickles">Raymond J. Pickles</name><name sortKey="Rockx, Barry" sort="Rockx, Barry" uniqKey="Rockx B" first="Barry" last="Rockx">Barry Rockx</name><name sortKey="Sheahan, Timothy" sort="Sheahan, Timothy" uniqKey="Sheahan T" first="Timothy" last="Sheahan">Timothy Sheahan</name></noCountry><country name="États-Unis"><region name="Caroline du Nord"><name sortKey="Sims, Amy C" sort="Sims, Amy C" uniqKey="Sims A" first="Amy C." last="Sims">Amy C. Sims</name></region><name sortKey="Baric, Ralph S" sort="Baric, Ralph S" uniqKey="Baric R" first="Ralph S." last="Baric">Ralph S. Baric</name><name sortKey="Denison, Mark R" sort="Denison, Mark R" uniqKey="Denison M" first="Mark R." last="Denison">Mark R. Denison</name><name sortKey="Johnston, Robert E" sort="Johnston, Robert E" uniqKey="Johnston R" first="Robert E." last="Johnston">Robert E. Johnston</name></country><country name="Suisse"><noRegion><name sortKey="Corti, Davide" sort="Corti, Davide" uniqKey="Corti D" first="Davide" last="Corti">Davide Corti</name></noRegion></country></tree></affiliations></record>Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Sante/explor/SrasV1/Data/Main/Exploration
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 003000 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd -nk 003000 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien
|wiki= Sante
|area= SrasV1
|flux= Main
|étape= Exploration
|type= RBID
|clé= PMC:2588415
|texte= Synthetic recombinant bat SARS-like coronavirus is infectious in cultured cells and in mice
}}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Exploration/RBID.i -Sk "pubmed:19036930" \
| HfdSelect -Kh $EXPLOR_AREA/Data/Main/Exploration/biblio.hfd \
| NlmPubMed2Wicri -a SrasV1
| This area was generated with Dilib version V0.6.33. |  |